Choate Investment Advisors’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-1,809
Closed -$320K 249
2020
Q1
$320K Hold
1,809
0.03% 190
2019
Q4
$346K Sell
1,809
-318
-15% -$57.4K 0.02% 184
2019
Q3
$358K Sell
2,127
-10
-0.5% -$1.63K 0.02% 182
2019
Q2
$358K Sell
2,137
-6
-0.3% -$831 0.02% 181
2019
Q1
$314K Buy
2,143
+591
+38% +$85.7K 0.02% 198
2018
Q4
$207K Sell
1,552
-645
-29% -$106K 0.01% 216
2018
Q3
$418K Buy
2,197
+556
+34% +$102K 0.02% 146
2018
Q2
$274K Sell
1,641
-664
-29% -$107K 0.02% 196
2018
Q1
$388K Sell
2,305
-204
-8% -$34.2K 0.02% 183
2017
Q4
$410K Sell
2,509
-375
-13% -$67.3K 0.02% 187
2017
Q3
$591K Buy
2,884
+2
+0.1% +$465 0.03% 164
2017
Q2
$701K Sell
2,882
-326
-10% -$76.6K 0.04% 146
2017
Q1
$766K Hold
3,208
0.04% 135
2016
Q4
$674K Sell
3,208
-160
-5% -$33.1K 0.04% 137
2016
Q3
$776K Buy
3,368
+966
+40% +$236K 0.05% 125
2016
Q2
$555K Sell
2,402
-4
-0.2% -$922 0.04% 143
2016
Q1
$645K Buy
+2,406
New +$689K 0.04% 129
2015
Q4
Sell
-3,200
Closed -$870K 288
2015
Q3
$870K Buy
+3,200
New +$983K 0.06% 109
2015
Q2
Sell
-3,457
Closed -$1.03M 265
2015
Q1
$1.03M Buy
3,457
+678
+24% +$193K 0.06% 112
2014
Q4
$715K Hold
2,779
0.04% 141
2014
Q3
$671K Hold
2,779
0.04% 150
2014
Q2
$620K Sell
2,779
-10
-0.4% -$2.07K 0.04% 155
2014
Q1
$574K Buy
2,789
+90
+3% +$17.8K 0.04% 161
2013
Q4
$453K Sell
2,699
-837
-24% -$131K 0.03% 187
2013
Q3
$509K Buy
3,536
+265
+8% +$35.3K 0.04% 164
2013
Q2
$413K Buy
+3,271
New +$370K 0.03% 178

Other funds holding AGN

Choate Investment Advisors's AGN Position: Q2 2020 in Review

Choate Investment Advisors sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 1,809 shares — an estimated $320K sold.

Choate Investment Advisors first reported a position in AGN in Q2 2013 and held it in 26 quarters. The position peaked at $1.03M in Q1 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Choate Investment Advisors reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Choate Investment Advisors sold 1,809 Allergan plc shares in Q2 2020, an estimated $320K.
  • Choate Investment Advisors first reported a position in Allergan plc in Q2 2013 and held it in 26 quarters.
  • Choate Investment Advisors's Allergan plc position peaked at $1.03M in Q1 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Choate Investment Advisors's 13F filing for Q2 2020, filed 23 Jul 2020.